1 Min Read
FRANKFURT, April 24 (Reuters) - Merck KGaA : * Announces positive outcome of iiib study for kuvan * Says positive outcome of study will enable submission of regulatory
application for a label extension later this year
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.